Popular Articles

Review Of Brazil's HIV/AIDS Treatment Programs Shows Importance Of Generic Drugs, Researchers Say
"Brazil has been successful in its nearly 20-year effort to treat people living with" HIV/AIDS, and generic medicines have been "a large part of the solution," according to a recent Health Affairs review, UPI reports (UPI, 7/14). The review examines Brazil"s passing of "a law in the 1990s that guaranteed citizens free and universal access to drugs for HIV and AIDS treatment" as well as the country"s production of generic HIV/AIDS medicines in public factories, AHN reports. "The [Brazilian] government also prompted drug companies to lower their prices by threatening to make generic versions of [patented] HIV and AIDS drugs in the public factories," writes AHN (Goodhue, 7/14).
generic viagra online
Petition Against Automatic Substitution Of Anti-epileptic Drugs
From time to time, Headway is made aware of worthy causes it believes it should provide its support to.
plastic surgery before after
News of the day
VIA Pharmaceuticals Announces Complete Enrollment In FDG-PET Phase 2 Study Of VIA-2291 In Cardiovascular Patients
VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, announced that it has completed enrollment in a Phase 2 clinical trial of its lead drug, VIA-2291 in patients who have experienced an acute coronary syndrome event such as a heart attack or unstable angina. The randomized, double blind, placebo-controlled study examines the impact of VIA-2291 on plaque inflammation as measured by Positron Emission Tomography with fluorodeoxyglucose tracer (FDG-PET), as well as other standard biomarkers of inflammation, over 24 weeks following such an acute event. A total of 52 patients have been enrolled in the study, which is expected to report data in the second half of 2009.
Diagnostics

NMC Responds To RCN Decision On Assisted Suicide, UK

The Nursing & Midwifery Council (NMC) has responded to the decision by the Royal College of Nursing (RCN) to move to a neutral position on assisted suicide. The NMC recognises that assisted suicide is an important and emotive issue for healthcare professionals and for members of the public. However, as the statutory regulator for nurses and midwives, the core purpose of the NMC is to safeguard the health and well-being of the public. It is the NMC"s statutory duty to remind nurses and midwives that they must practice within their code of professional conduct (The Code ) and within the context of national laws. The law on assisted suicide has not changed. Commenting on the RCN"s decision, NMC Chief Executive & Registrar, Kathy George, said: "Despite the RCN"s move to a neutral position on assisted suicide, nurses and midwives are personally accountable for their actions and must act lawfully at all times. This is clearly stated in their code of professional conduct. Assisting the suicide of a patient is against the law". Nursing & Midwifery Council


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):